216 related articles for article (PubMed ID: 26905631)
21. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee T; Southern KW
Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
[TBL] [Abstract][Full Text] [Related]
22. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
Jefferson TO; Demicheli V; Di Pietrantonj C; Jones M; Rivetti D
Cochrane Database Syst Rev; 2006 Jul; (3):CD001265. PubMed ID: 16855962
[TBL] [Abstract][Full Text] [Related]
23. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
Ng SM; Moore HS
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD003424. PubMed ID: 27546383
[TBL] [Abstract][Full Text] [Related]
24. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
25. Vaccines for preventing influenza in people with cystic fibrosis.
Dharmaraj P; Smyth RL
Cochrane Database Syst Rev; 2009 Oct; (4):CD001753. PubMed ID: 19821281
[TBL] [Abstract][Full Text] [Related]
26. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
Ng SM; Franchini AJ
Cochrane Database Syst Rev; 2014 Jul; (7):CD003424. PubMed ID: 25019293
[TBL] [Abstract][Full Text] [Related]
27. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
Jefferson T; Jones M; Doshi P; Del Mar C
BMJ; 2009 Dec; 339():b5106. PubMed ID: 19995812
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis.
Thornton J; Rangaraj S
Cochrane Database Syst Rev; 2012 Mar; (3):CD006838. PubMed ID: 22419317
[TBL] [Abstract][Full Text] [Related]
29. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis.
Thornton J; Rangaraj S
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD006838. PubMed ID: 26798057
[TBL] [Abstract][Full Text] [Related]
31. Insulin and oral agents for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2016 Apr; 4():CD004730. PubMed ID: 27087121
[TBL] [Abstract][Full Text] [Related]
32. Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
Green J; Carroll W; Gilchrist FJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012798. PubMed ID: 30075058
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic stem cell transplantation for people with ß-thalassaemia major.
Jagannath VA; Fedorowicz Z; Al Hajeri A; Sharma A
Cochrane Database Syst Rev; 2014 Oct; (10):CD008708. PubMed ID: 25316103
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D supplementation for cystic fibrosis.
Ferguson JH; Chang AB
Cochrane Database Syst Rev; 2014 May; (5):CD007298. PubMed ID: 24823922
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological agents (anti-inflammatory and analgesic) for managing symptoms in people with cystic fibrosis-related arthritis.
Thornton J; Rangaraj S
Cochrane Database Syst Rev; 2008 Jan; (1):CD006838. PubMed ID: 18254117
[TBL] [Abstract][Full Text] [Related]
36. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.
Shun-Shin M; Thompson M; Heneghan C; Perera R; Harnden A; Mant D
BMJ; 2009 Aug; 339():b3172. PubMed ID: 19666987
[TBL] [Abstract][Full Text] [Related]
37. Oscillating devices for airway clearance in people with cystic fibrosis.
Morrison L; Agnew J
Cochrane Database Syst Rev; 2009 Jan; (1):CD006842. PubMed ID: 19160305
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic stem cell transplantation for people with ß-thalassaemia major.
Jagannath VA; Fedorowicz Z; Al Hajeri A; Sharma A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008708. PubMed ID: 27900772
[TBL] [Abstract][Full Text] [Related]
39. Autogenic drainage for airway clearance in cystic fibrosis.
McCormack P; Burnham P; Southern KW
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009595. PubMed ID: 28984368
[TBL] [Abstract][Full Text] [Related]
40. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Smith S; Ratjen F; Remmington T; Waters V
Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
